We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pharmatek Announces Acquisition of Additional Xcelodose® 600S System

News   Feb 07, 2013

 
Pharmatek Announces Acquisition of Additional Xcelodose® 600S System
 
 
 

RELATED ARTICLES

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

Fast-acting Psychedelic Eases Depression and Anxiety

News

Researchers have discovered that use of the synthetic psychedelic, 5-methocy-N,-N-dimethyltryptamine, appears to be associated with unintended improvements in self-reported depression and anxiety when given in a ceremonial group setting.

READ MORE

Study Ties Common Heartburn Medications to Kidney Disease

News

Common medications prescribed to treat heartburn, acid reflux and ulcers are linked to increased risks for kidney failure and chronic kidney disease, found a recent University at Buffalo study.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE